Endoxaban does not protect against stroke
Description
BACKGROUND:
Current data indicate a global stroke incidence of about 258/100,000/year. Despite the many
times dramatic consequences for an individual and the human society, stroke is still not preventable
for sure. Is Endoxaban of any benefit in this regard?
MATERIAL AND METHODS:
The relationship between endoxaban and stroke has been re-analysed. New statistical methods
were used.
RESULTS:
Endoxaban does not protect people against stroke (P Value = 0.07199244). Statins protect people
against venous thromboembolism (P Value = 0.00468021).
CONCLUSION:
It appears to be necessary to re-think the unconcerned use of endoxaban and of other new oral
anticoagulants (NOAK) against stroke.
Notes
Files
Barukcic_Statins_and_Thromboembolism_Causation_2024_Vol_19_No_10_pp_5_38.pdf
Files
(416.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:b98bce82eea825e90e5b30b6ffa74b12
|
416.5 kB | Preview Download |